Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Daiichi Sankyo’s Hypertension Drug Hits Mark in Diabetic Nephropathy Trial

Tokyo-based Daiichi Sankyo’s ESAX-DN Phase III trial of esaxerenone met the primary endpoint in diabetic nephropathy.

Read More »

Bayer Funds New Joint Research Lab with $30 Million Over 5 Years

Bayer, Brigham and Women’s Hospital, and Massachusetts General Hospital launched a joint laboratory to research new drugs to treat chronic lung diseases.

Read More »

Epigenetic Drug Developer Omega Launches

Omega Therapeutics debuted with a focus on epigenetics, the study of changes in gene expression that do not involve changes to the DNA sequence.

Read More »

Outcome Health Launches New Campaign to Transform “Point of Care” through “Moments of Care”

Outcome Health launched “In These Rooms” – a bespoke campaign to transform the strategy of the industry from “point of care” to “moments of care.”

Read More »

Alfasigma USA Reintroduces IBS-C Drug Zelnorm to U.S. Market

Zelnorm was relaunched by Alfasigma USA for the treatment of irritable bowel syndrome with constipation (IBS-C).

Read More »

Chinook Launches to Tackle Kidney Disease

British Columbia-based Chinook Therapeutics burst onto the scene with $65 million in hand and a goal of driving a portfolio of compounds aimed at kidney diseases into the clinic by 2021.

Read More »

Top 200 Medicines Annual Report 2019: The king of medicines

Humira’s dominance continues as the world’s top-selling prescription product as the biologic therapy is the first drug to exceed $20 billion in annual global sales.

Read More »

Sanofi Reports Strong Second-Quarter 2019

Sanofi reported overall net sales increased by 5.5 percent for second-quarter 2019, driven by Sanofi Genzyme, Sanofi Pasteur and emerging markets.

Read More »

Havas Health & You Launches Havas ECS

Havas Health & You introduced Havas ECS, a specialized strategic communications advisory and education company focused on the importance and value of foundational scientific knowledge on the endocannabinoid system,

Read More »

LevLane Named Agency of Record for Vital USA

LevLane Advertising was named agency of record by innovative health technology company Vital USA Inc.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom